Ferreira, Victor H.
Solera, Javier T. http://orcid.org/0000-0001-6833-6625
Hu, Queenie
Hall, Victoria G.
Arbol, Berta G. http://orcid.org/0000-0003-2880-3780
Rod Hardy, W.
Samson, Reuben
Marinelli, Tina
Ierullo, Matthew http://orcid.org/0000-0001-9638-873X
Virk, Avneet Kaur
Kurtesi, Alexandra
Mavandadnejad, Faranak
Majchrzak-Kita, Beata
Kulasingam, Vathany
Gingras, Anne-Claude http://orcid.org/0000-0002-6090-4437
Kumar, Deepali http://orcid.org/0000-0003-1961-0477
Humar, Atul http://orcid.org/0000-0002-1751-7159
Funding for this research was provided by:
Public Health Agency of Canada (2122-HQ-000067, 2122-HQ-000067)
Article History
Received: 21 April 2022
Accepted: 22 July 2022
First Online: 4 August 2022
Competing interests
: D.K. has received research grant from Roche, GSK, and advisory fees from Roche, GSK, Sanofi, Merck and Exevir. A.H. has received research grants from Roche and Merck and advisory fees from Merck and Takeda. A.C.G. has received research funds from a research contract with Providence Therapeutics Holdings, Inc for other projects. No other authors have competing interests to disclose.